Sell-side & buy-side advisory · U.S. pharmacy sector

The quiet market for exceptional pharmacy assets.

Pharmacy Brokerage Services represents owners and acquirers in the confidential sale, purchase, and recapitalization of specialty, compounding, and independent pharmacy businesses — with the discretion the moment demands.

Current mandate PBS-0417 Turnkey cGMP 503B sterile compounding facility — Southern California Profile redacted available under NDA

The practice

A boutique advisory built around a single sector — and a single standard of discretion.

We do one thing: move pharmacy businesses between owners cleanly, confidentially, and at the right value. Buyers and sellers work with the same team from first conversation to close.

01

Sell-side representation

Owner-aligned exits, run end to end. We prepare the business, control the narrative, and take the process to a curated set of qualified buyers — never a public auction.

02

Buy-side mandates

For strategic and financial buyers, we source and secure hard-to-find pharmacy assets — including proprietary opportunities that are never openly marketed.

03

Valuation & deal packaging

Defensible valuation paired with institutional-grade materials — blind teaser, full confidential information memorandum, and a diligence-ready data room.

04

Confidential marketing

Pre-qualified outreach under NDA that surfaces genuine interest while protecting your name, your staff, and your patient relationships until it matters.

The confidential index

Assets come to market quietly.

A live mandate — and the categories we represent. Identifying detail stays redacted until a mutual non-disclosure agreement is in place.

Ref.AssetGeographyStatus
PBS-0417
Turnkey cGMP 503B sterile compounding facility
Southern California
Live · under NDA

Mandate types we represent

PBS · 
Specialty pharmacy platform
Pre-NDA
PBS · 
Independent & retail pharmacy group
Pre-NDA
PBS · 
Long-term care & closed-door pharmacy
Pre-NDA
PBS · 
Home infusion & specialty distribution
Pre-NDA

Full CIM available upon execution of a mutual NDA.

How a mandate comes to market

Five disciplined stages, one confidential process.

01

Valuation & readiness

We establish a defensible range and prepare the business to withstand buyer diligence before anyone sees it.

02

Confidential packaging

A blind teaser and full CIM tell the story compellingly — without exposing your identity.

03

Curated outreach

We approach a short list of qualified strategic and financial buyers under NDA — quietly, never at auction.

04

Diligence & terms

We run the data room, manage competing interest, and negotiate structure to protect value and certainty.

05

Close & transition

We carry the transaction through signing, funding, and a clean operational handoff.

Sectors we cover

Depth where it counts.

We speak the language buyers underwrite — licensure, REMS, payer mix, and the regulatory posture unique to each pharmacy model.

503A / 503B

Sterile & non-sterile compounding

Outsourcing facilities and compounding pharmacies.

Specialty

Specialty pharmacy

Limited-distribution, high-touch therapeutic platforms.

Retail

Independent & retail

Single stores to multi-location independent groups.

LTC

Long-term care & closed-door

Institutional, assisted-living, and correctional service.

Infusion

Home infusion & distribution

Ambulatory infusion and specialty distribution assets.

Why Pharmacy Brokerage Services

Sector fluency and absolute discretion — in the same firm.

Sector specialization

We only do pharmacy. That means we can price the things generalist brokers miss — DEA and state licensure, REMS obligations, 340B exposure, and payer concentration.

Confidential by design

Your name stays protected until an NDA is signed. Discretion isn't an add-on to our process — it is the process.

Institutional-grade materials

Every mandate is packaged to the standard buyers expect: a blind teaser, a complete CIM, and a diligence-ready data room.

Curated buyer access

Direct relationships with the strategic acquirers, platforms, and financial sponsors actively deploying capital into pharmacy today.

Start a confidential conversation

Considering a sale — or a strategic acquisition?

Every conversation begins in confidence. Reach out to discuss a potential mandate, a valuation view, or a specific acquisition target. No obligation, and nothing leaves the room.

Charlie LeBon
Chief Business Development Officer
charlie@pbsmna.com www.pbsmna.com
Please add your name.
Please add a valid email.
Please choose one.
Please add a short message.

Submitting opens a pre-addressed, confidential email to Charlie LeBon. Your message is not stored on this site.